Tien-Hua Chen

Tien-Hua Chen

Auto-generated profile, based on publicly available information

Tien-Hua Chen

Department of Oncology, Taipei Veterans General Hospital, Taipei, Taiwan; School of Medicine, College of Medicine, National Yang Ming Chiao Tung University

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 November 2022 in Neoplasia
Verified
Journal Article
Open access
TLTsung Lun Lee
Tsung Lun Lee
TCTien-Hua Chen
Tien-Hua Chen
YKYing-Ju Kuo
Ying-Ju Kuo
HLHsin-Yi Lan
Hsin-Yi Lan
Muh-Hwa YangMuh-Hwa Yang
Muh-Hwa Yang
PCPen-Yuan Chu
Pen-Yuan Chu
• Tumor-associated tissue eosinophilia (TATE)-enriched head and neck squamous cell carcinoma (HNSCC) is correlated with aggressive pathological features and poor prognosis. • TATE induces HNSCC metastasis through CCL2 release. • TATE increases angiogenesis in neighboring HNSCC. • TATE coexists with immunosuppressive tumor microenvironment in HNSCC.

19 May 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
SBSumona Biswas
Sumona Biswas
Sumeet PatiyalSumeet Patiyal
Sumeet Patiyal
TCTien-Hua Chen
Tien-Hua Chen
ASAmos Stemmer
Amos Stemmer
SDSaugato Rahman Dhruba
Saugato Rahman Dhruba
EREytan Ruppin
Eytan Ruppin
Head and neck squamous cell carcinoma (HNSC) is a prevalent malignancy associated with poor prognosis despite recent therapeutic advances. We hypothesized that a comprehensive understanding of the spatial heterogeneity and organization of the tumor microenvironment (TME) can substantially improve risk stratification and prediction of treatment response in HNSC. As spatial transcriptomics (ST) remains labor-intensive and costly, we developed HEiST (H&E-Inferred Spatial Transcriptomics), a deep learning framework that predicts spatially resolved gene expression profiles directly from routine hematoxylin and eosin (H&E)-stained histology slides. After rigorous validation across two independent external ST cohorts, we applied HEiST to infer spatial transcriptomes across 1,500 HNSC patient tumors spanning two publicly available datasets and two newly generated cohorts, one treated with concurrent chemoradiotherapy (CCRT) and one with immunotherapy. This large-scale analysis uncovered reproducible spatial clusters characterizing the HNSC TME, defining two distinct prognostic Spatiotypes , Immune–Exhausted and Immune–Activated, with significantly distinct survival outcomes. Critically, spatial cluster composition accurately predicts HPV status and yields treatment response predictors for both CCRT/radiotherapy and immunotherapy that outperform costly gene-expression and direct image-based approaches. Notably, the ST cluster–based predictor of immunotherapy response markedly surpasses the performance of commonly used FDA-approved biomarkers, including CPS, TPS, and their combination. To the best of our knowledge, this represents the first virtual spatial profiling effort and the most comprehensive large-scale spatial TME analysis in HNSC to date. HEiST thus introduces a scalable, low-cost, and spatially grounded biomarker discovery for precision oncology in HNSC.